Literature DB >> 28810579

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Qiongyan Zou1, Wenjun Yi1, Jianghai Huang1, Fenfen Fu1, Gannong Chen1, Dewu Zhong1.   

Abstract

MicroRNAs (miRs) are a type of small non-coding RNA that serve crucial roles in the development and progression of breast cancer. However, the exact role and underlying molecular mechanism of miR-375 in mediating the growth and metastasis of breast cancer remains unknown. In the present study, reverse transcription-quantitative polymerase chain reaction and western blot analysis were conducted to examine RNA and protein expression. A luciferase reporter assay was performed to determine the association between miR-375 and paired box 6 (PAX6). The results of the current study indicate that the expression of miR-375 was reduced in breast cancer tissues compared with matched adjacent normal tissues. Transfection with miR-375 mimics led to a significant increase in levels of miR-375 in human breast cancer Michigan Cancer Foundation (MCF)-7 cells (P<0.05). The increase in miR-375 expression caused a significant decrease in the viability, migration and invasion of MCF-7 cells (P<0.05), accompanied by a reduced expression of matrix metalloproteinase (MMP) 2 and MMP9 proteins. Luciferase reporter assay identified PAX6 as a novel target of miR-375 and miR-375 in turn, negatively regulated the protein expression of PAX6 in MCF-7 cells. By contrast, overexpression of PAX6 led to a significant increase in MCF-7 cell viability (P<0.01) but did not affect the migration and invasion of MCF-7 cells, suggesting that the inhibitory effect of miR-375 on MCF-7 cell viability may be occurring, in part, via the direct targeting of PAX6.

Entities:  

Keywords:  breast cancer; invasion; microRNA-375; migration; paired box 6; viability

Year:  2017        PMID: 28810579      PMCID: PMC5525589          DOI: 10.3892/etm.2017.4593

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  36 in total

Review 1.  Development of pancreatic islets (review).

Authors:  T Yamaoka; M Itakura
Journal:  Int J Mol Med       Date:  1999-03       Impact factor: 4.101

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  microRNAs in breast cancer development and treatment.

Authors:  Danila Serpico; Leonardo Molino; Serena Di Cosimo
Journal:  Cancer Treat Rev       Date:  2013-11-14       Impact factor: 12.111

4.  MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.

Authors:  Lizandra Jimenez; Ved P Sharma; John Condeelis; Thomas Harris; Thomas J Ow; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Arch Pathol Lab Med       Date:  2015-07-14       Impact factor: 5.534

5.  Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.

Authors:  Yang Wen; Jing Han; Jianguo Chen; Jing Dong; Yongxiang Xia; Jibin Liu; Yue Jiang; Juncheng Dai; Jianhua Lu; Guangfu Jin; Jiali Han; Qingyi Wei; Hongbing Shen; Beicheng Sun; Zhibin Hu
Journal:  Int J Cancer       Date:  2015-04-21       Impact factor: 7.396

Review 6.  MicroRNAs as mediators of viral evasion of the immune system.

Authors:  Bryan R Cullen
Journal:  Nat Immunol       Date:  2013-02-15       Impact factor: 25.606

7.  PAX6, a novel target of microRNA-7, promotes cellular proliferation and invasion in human colorectal cancer cells.

Authors:  Yanwen Li; Yuehui Li; Yanhong Liu; Pingli Xie; Feng Li; Guancheng Li
Journal:  Dig Dis Sci       Date:  2013-11-02       Impact factor: 3.199

Review 8.  Roles of microRNAs in atherosclerosis and restenosis.

Authors:  Li-Jing Chen; Seh Hong Lim; Yi-Ting Yeh; Sheng-Chieh Lien; Jeng-Jiann Chiu
Journal:  J Biomed Sci       Date:  2012-08-29       Impact factor: 8.410

9.  MicroRNA-375 plays a dual role in prostate carcinogenesis.

Authors:  João Ramalho-Carvalho; Filipa Quintela Vieira; Carmen Jerónimo; Pedro Costa-Pinheiro; Jorge Torres-Ferreira; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique
Journal:  Clin Epigenetics       Date:  2015-04-10       Impact factor: 6.551

10.  miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma.

Authors:  Jie Luo; Jianhui Wu; Zenghong Li; Hao Qin; Bin Wang; Thian-Sze Wong; Weiqiang Yang; Qing-Ling Fu; Wenbin Lei
Journal:  Biomed Res Int       Date:  2014-08-12       Impact factor: 3.411

View more
  11 in total

1.  [Construction of a lentiviral vector carrying short?hairpin RNA targeting PAX6 and its effect on proliferation of glioma U251 cells in vitro].

Authors:  Xiao-Hong Liao; Wei-Lan Yin; Fang Wang; Li-Xiang Wu; Bai-Sheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  A positive feedback regulation between long noncoding RNA SNHG1 and YAP1 modulates growth and metastasis in laryngeal squamous cell carcinoma.

Authors:  Ling Gao; Hua Cao; Xiulian Cheng
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

3.  Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Authors:  Adrien Costantini; Catherine Julie; Coraline Dumenil; Zofia Hélias-Rodzewicz; Julie Tisserand; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Etienne Giroux Leprieur
Journal:  Oncoimmunology       Date:  2018-04-20       Impact factor: 8.110

4.  NF-κB inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.

Authors:  Sotirios G Doukas; Dimitra P Vageli; Clarence T Sasaki
Journal:  J Cell Mol Med       Date:  2018-03-08       Impact factor: 5.310

5.  Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

Authors:  Meng Jin; Daili Gao; Rongchun Wang; Attila Sik; Kechun Liu
Journal:  Oncol Rep       Date:  2020-06-11       Impact factor: 3.906

6.  Knockdown of lncRNA XIST Suppresses Cell Tumorigenicity in Human Non-Small Cell Lung Cancer by Regulating miR-142-5p/PAX6 Axis.

Authors:  Qingfeng Jiang; Wenqun Xing; Jinhua Cheng; Yongkui Yu
Journal:  Onco Targets Ther       Date:  2020-06-02       Impact factor: 4.147

7.  miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2.

Authors:  Elif Değerli; Vildan Torun; Demet Cansaran-Duman
Journal:  Biol Res       Date:  2020-05-04       Impact factor: 5.612

8.  LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells.

Authors:  Xian Hu Zhang; Bing Feng Li; Jie Ding; Lei Shi; Huo Ming Ren; Kui Liu; Chuan Cai Huang; Fu Xiao Ma; Xin Yao Wu
Journal:  Cancer Manag Res       Date:  2020-05-29       Impact factor: 3.989

9.  Protecting Pax6 3' UTR from MicroRNA-7 Partially Restores PAX6 in Islets from an Aniridia Mouse Model.

Authors:  Kevin Yongblah; Spencer C Alford; Bridget C Ryan; Robert L Chow; Perry L Howard
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-01       Impact factor: 8.886

10.  Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.

Authors:  Chen Yan; Jintao Hu; Yipeng Yang; Hong Hu; Dongxian Zhou; Min Ma; Nan Xu
Journal:  Mol Med Rep       Date:  2019-09-10       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.